RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA

Clinical trials for RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested to fight tough blood cancers

Disease control Ongoing

This study is testing if adding a new drug called selinexor to the standard chemotherapy regimen (RCHOP) is safe and more effective for treating B-cell non-Hodgkin's lymphoma. It will first find the safest dose of the combination, then see how well it works for newly diagnosed pa…

Matched conditions: RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA

Get alerted when new RECURRENT EXTRANODAL MARGINAL ZONE LYMPHOMA trials appear

New drug combo tested to fight tough blood cancers